A carregar...
Two roads for oncolytic immunotherapy development
Oncolytic viruses are an emerging class of immunotherapy agents for cancer treatment. In this issue of JITC, Machiels et al. reports early phase data from an oncolytic adenovirus given by intravenous (IV) administration. While this may allow easy access to metastatic lesions, there is limited data s...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359832/ https://ncbi.nlm.nih.gov/pubmed/30709365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0515-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|